1-64050507-ATTT-ATTTT
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_005012.4(ROR1):c.452-165dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0707 in 142,882 control chromosomes in the GnomAD database, including 957 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_005012.4 intron
Scores
Clinical Significance
Conservation
Publications
- hearing loss, autosomal recessive 108Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nonsyndromic genetic hearing lossInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005012.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ROR1 | TSL:1 MANE Select | c.452-179_452-178insT | intron | N/A | ENSP00000360120.1 | Q01973-1 | |||
| ROR1 | TSL:1 | c.452-179_452-178insT | intron | N/A | ENSP00000360121.1 | Q01973-3 | |||
| ROR1 | TSL:5 | n.486-179_486-178insT | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.0706 AC: 10084AN: 142854Hom.: 953 Cov.: 30 show subpopulations
GnomAD4 genome AF: 0.0707 AC: 10106AN: 142882Hom.: 957 Cov.: 30 AF XY: 0.0693 AC XY: 4812AN XY: 69466 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.